N/A
N=38
Intervention to Increase Screening for Glucocorticoid Induced Diabetes
Diabetes Mellitus
Bottom Line
View on ClinicalTrials.gov: NCT01743963 ↗Enrolled (actual)
38
Serious AEs
0.0%
Results posted
Jul 2015
Primary outcome: Primary: Delay Interval (Days From Randomization Until the Provider Signs the Order for a hgbA1C Level). — 12; 104 Days
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Decision support (Behavioral); Usual Care (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Eastern Colorado Health Care System
- Primary completion
- Mar 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Delay Interval (Days From Randomization Until the Provider Signs the Order for a hgbA1C Level). |
12; 104 | — |
| SECONDARY Feasibility/Reach/Adoption |
— | — |
| SECONDARY Feasibility/Reach/Adoption |
— | — |
| SECONDARY Feasibility/Reach/Adoption |
— | — |
| SECONDARY Feasibility/Reach/Adoption |
— | — |
Summary
Using glucocorticoid induced diabetes (GID) we will conduct a small feasibility randomized intervention trial to improve GID management for veterans who are prescribed chronic glucocorticoids. Approximately 20 primary care providers (caring for approximately 100 veterans on chronic steroids) will receive decisional support (automatically-derived orders for hemoglobin A1C, to be co-signed by providers). Approximately 20 providers (caring for 100 veterans) who did not receive decisional support will serve as the control population. We will measure the time from randomization until the provider signs an order for hemoglobin A1C for both groups. The trial will be conducted at the VA's Eastern Colorado Health Care System (ECHCS) and will last approximately 6 months. After the completion of the trial for each provider, we will conduct a brief interview and survey of the participating providers to assess the acceptability of decisional support interventions to manage GID [protocol, page 1-2]. No patient data (PHI) will be collected by the providers.
Eligibility Criteria
Inclusion criteria
- Must be 18-90 years old
- Must be served by the ECHCS VA sytem
- Must have chronic glucocorticoid exposure (greater than or equal to 90 days of oral glucocorticoids)
- Eligible providers will consist of those primary care practitioners within the ECHCS with at least one patient meeting the above criteria. For each veteran, the primary care provider (PCP) will be defined as the patient's current general internal medicine or family practice practitioner. In the rare instance in which the patient has no PCP within the VA system, the specialist with the greatest number of patient encounters during the past 12 months will be eligible for inclusion. For every patient, only one provider will be randomized (to avoid multiple exposure to the intervention for some patients). The consent procedure is described below.
Exclusion Criteria
- Veterans who have had a hgbA1C test within the previous 12 months will be excluded.
- Providers without eligible patients (described above), will be excluded.
- Providers declining to give consent will be excluded.
Data sourced from ClinicalTrials.gov (NCT01743963). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.